Kymera Therapeutics Inc. (KYMR)
NASDAQ: KYMR
· Real-Time Price · USD
34.63
0.36 (1.05%)
At close: May 01, 2025, 3:59 PM
34.55
-0.25%
After-hours: May 01, 2025, 04:27 PM EDT
Kymera Therapeutics Revenue
Kymera Therapeutics reported an annual revenue of $47.07M, reflecting a -40.11% growth. For the quarter ending December 31, 2024, Kymera Therapeutics generated $7.39M in revenue.
Revenue (ttm)
$47.07M
Revenue Growth
-40.11%
Price / Sales Ratio
64.14
Revenue / Employee
$250.38K
Employees
188
Market Cap
2.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 47.07M | -40.11% |
Dec 31, 2023 | 78.59M | +67.84% |
Dec 31, 2022 | 46.83M | -35.71% |
Dec 31, 2021 | 72.83M | +114.00% |
Dec 31, 2020 | 34.03M | n/a |